TIDMMHC

RNS Number : 4278X

MyHealthChecked PLC

05 January 2022

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

MyHealthChecked Plc

("MyHealthChecked", "MHC" or the "Company")

Retail partnership with Lloyds Pharmacy for COVID-19 Antigen testing

MyHealthChecked Plc (AIM: MHC), the consumer home-testing healthcare company, has signed a contract with AAH Pharmaceuticals Limited ("Lloyds Pharmacy") for supply of the Fit to Fly/Pre-departure rapid antigen test. The test can be taken at home prior to travel, or overseas prior to returning to the UK, with results verified by a trained professional within two hours of completing the test, and provides the passenger with a certificate suitable for outbound or return travel.

The rapid antigen tests and accompanying verification service provided by MyHealthChecked will be the only COVID rapid antigen test sold through Lloyds Pharmacy and will accompany the portfolio of PCR kits that the pharmacy began selling online in August.

The Fit to Fly rapid tests will launch at Lloyds Pharmacy in January 2022.

Penny McCormick, Chief Executive Officer of MyHealthChecked Plc, said:

"I am pleased to build on our existing relationship with Lloyds Pharmacy with our new COVID-19 antigen test service for travel. Lloyds Pharmacy is already well established with a PCR testing portfolio that includes inbound PCR testing for fully vaccinated and non-vaccinated customers. We are delighted to be supporting Lloyds Pharmacy further with their growing COVID testing portfolio and working with them as testing protocols for travel continue to evolve."

 
 MyHealthChecked plc                                                     www.myhealthchecked.com 
 P enny McCormick , Chief Executive                                              via Walbrook PR 
  Officer 
 Gareth Davies, Chief Financial and 
  Operations Officer 
 
 SPARK Advisory Partners Limited (NOMAD)                                Tel: +44 (0)20 3368 3550 
 Neil Baldwin 
 
 Oberon Capital Ltd (Broker)                                            Tel: +44 (0)203 179 5344 
 Mike Seabrook                                                mikeseabrook@oberoninvestments.com 
 
 Walbrook PR Ltd (Media &          Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com 
  IR) 
 Paul McManus / Alice Woodings                             Mob: +44(0)7980 541 893 / +44 (0)7407 
                                                                                         804 654

About MyHealthChecked PLC ( www.myhealthcheckedplc.com )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests. MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests, now in development following the acquisition of The Genome Store in November 2020. The tests will be made available online, and would be viable for over the counter purchase.

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCUPUUAGUPPGMC

(END) Dow Jones Newswires

January 05, 2022 01:59 ET (06:59 GMT)

Concepta (LSE:CPT)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024 Haga Click aquí para más Gráficas Concepta.
Concepta (LSE:CPT)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024 Haga Click aquí para más Gráficas Concepta.